13F Holdings
中文EN

FUNI Hypha Labs, Inc.

Services-Testing Laboratories · OTC · SEC CIK 1502966 · Fiscal year ends 09/30

Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY36.7%
TTM EPS YoY66.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-729.6%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets4,618.5%
Debt / equity—
Current ratio0.01x
Interest coverage-4.40x

Cash quality & payout

Operating cash flow / net income0.30x
Accruals ratio-512.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-09-30FY20242024-09-30FY20232023-09-30FY20222022-09-30FY20212021-09-30
Income statement
Revenue———$2.70M$2.50M
Cost of revenue———$1.63M$1.79M
Gross profit———$1.07M$715,165
SG&A expense$1.42M$943,691$103,298$495,762$934,143
Operating income-$3.00M-$1.83M-$437,388-$1.15M-$772,448
Interest expense$106,143$201,769$364,267$244,586$144,957
Pretax income-$3.10M-$1.36M-$681,655——
Income tax—$14,189———
Net income-$3.10M-$785,429$246,774-$2.06M-$686,503
EBITDA-$2.99M-$1.83M—-$946,314-$480,315
EPS (basic)-0.02-0.010.00-0.03-0.01
EPS (diluted)-0.02-0.010.00-0.03-0.01
Weighted avg. shares (diluted)135.15M101.35M83.93M74.17M65.87M
Banking
Net interest income———$63,087$930
Balance sheet
Cash & equivalents$38,118$91,166$271,006$56,168$295,932
Receivables———$335,085$214,900
Current assets$320,531$410,190$765,798$562,104$826,865
PP&E, net$62,507$26,609—$55,000$647,252
Total assets$409,218$493,805$1.41M$1.34M$1.89M
Current liabilities$1.12M$1.39M$3.12M$2.95M$2.01M
Total liabilities$2.51M$1.42M$3.28M$3.75M$2.94M
Shareholders' equity-$2.44M-$1.26M-$2.21M-$2.74M-$1.05M
Shares outstanding147.12M123.05M87.10M75.15M71.23M
Cash flow statement
Operating cash flow-$379,975-$1.03M$112,525-$184,786-$135,968
Capital expenditure$32,966$27,655—$17,722$56,206
Free cash flow-$412,941-$1.06M—-$202,508-$192,174
Investing cash flow-$32,966$2.15M$263,333-$660,371-$286,206
Financing cash flow$359,893-$1.29M-$161,020$605,393$635,357
Depreciation & amortization$10,818$1,046—$204,151$292,133
Stock-based compensation$1.85M$733,748$59,154$566,233$403,886

Free plan shows the latest 5 periods; Pro shows all 15 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.